Seres Therapeutics, Inc.
NASDAQ:MCRBBiotechnology
Healthcare
$5.28 +1.70%
+$0.11 today
- Market cap
- $51.13M
- Beta
- 0.11
- P/E (TTM)
- -1.3
- EPS (TTM)
- -$4.89
52W Low $5.31High $29.98
Volume 0.04M
Average 0.06M
Balance Sheet
Inspect the capital base behind the business.
Assets
$138.19M
FY 2025 · Annual
-1.2% YoYLiabilities
$93.97M
FY 2025 · Annual
-25.4% YoYEquity
$44.22M
FY 2025 · Annual
+220.8% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 180M | 163.03M | 127.97M | 30.79M | 45.77M |
| Short-term Investments | 110.7M | 18.31M | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 4.75M | 360K |
| Inventory | 0 | 0 | 29.65M | 0 | 0 |
| Other Current Assets | 0 | 13.42M | 17.8M | 3.13M | 3.25M |
| Total Current Assets | 303.63M | 194.76M | 175.41M | 38.67M | 49.38M |
| Property, Plant & Equipment (Net) | 36.15M | 133.97M | 108.03M | 92.44M | 80.12M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 495K | 9.59M | 9.59M | 8.67M | 8.67M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 14.59M | 10.47M | 65.57M | 31K | 31K |
| Total Non-current Assets | 51.23M | 154.02M | 183.19M | 101.14M | 88.82M |
| Total Assets | 354.86M | 348.78M | 358.6M | 139.81M | 138.19M |
| Account Payables | 13.74M | 17.44M | 3.64M | 4.08M | 1.68M |
| Short-term Debt | 0 | 456K | 0 | 0 | 10.39M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 16.82M | 4.26M | 7.73M | 0 | 0 |
| Other Current Liabilities | 21.1M | 34.77M | 59.19M | 17.75M | 4.57M |
| Total Current Liabilities | 82.26M | 85.6M | 98.66M | 41.22M | 19.32M |
| Long-term Debt | 24.64M | 50.59M | 101.54M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 87M | 92.43M | 95.36M | 0 | 0 |
| Other Non-current Liabilities | 11.5M | 1.44M | 16.24M | 1.84M | 2.08M |
| Total Non-current Liabilities | 141.09M | 252.41M | 304.8M | 84.8M | 74.65M |
| Total Liabilities | 223.35M | 338M | 403.46M | 126.03M | 93.98M |
| Common Stock | 92K | 125K | 135K | 173K | 10K |
| Retained Earnings | (614.35M) | (864.51M) | (978.24M) | (978.1M) | (972.4M) |
| Accumulated OCI | (60K) | (12K) | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 131.51M | 10.78M | (44.86M) | 13.78M | 44.22M |
| Total Debt | 49.21M | 162.59M | 198.78M | 91.64M | 82.97M |
| Net Debt | (130.79M) | (440K) | 70.82M | 60.85M | 37.2M |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $29.8M |
| Receivables | $233.0K |
| Other Current | $1.8M |
| Total Current Assets | $31.8M |
| PP&E (Net) | $77.1M |
| Long-term Investments | $8.7M |
| Other Non-current | $31.0K |
| Total Non-current Assets | $85.8M |
| Total Assets | $117.6M |
Analysis
Selected assets total $117.6M for Latest. The largest visible component is PP&E (Net) at $77.1M, about 65.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| EFFECT | EFFECT filing | Aug 21, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 18, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 18, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 18, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 18, 2026 |
How much cash does MCRB have?
Seres Therapeutics, Inc. (MCRB) reported $45.77M in cash and equivalents in fiscal 2025.
How much debt does MCRB carry?
Seres Therapeutics, Inc. (MCRB) reported $82.97M of total debt, with net debt of $37.20M.
Continue the stock analysis
Jump to another research area for this company.